Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Molecular Sensing

Molecular Sensing is listed as a small business research supplier in the Scientist.com network, with 4 sites in 2 countries.

View Molecular Sensing on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 4
Countries 2

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

In Vitro Assays

  • Assay Development Construct or create new assays or modify existing ones.

In Vitro Pharmacology

  • Drug Target Assays Gain insight into the selectivity and mode-of-action of a compound's pharmacological targets.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States Nashville, Los Gatos 3 sites
  • Germany Idstein 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering. Conformational change is the hallmark of protein dynamics and is intimately related to protein function. BSI detects binding-induced target conformational...

Show the full description

Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractable target binding assays in native-like, free-solution environments — no tags or tethering.

Conformational change is the hallmark of protein dynamics and is intimately related to protein function. BSI detects binding-induced target conformational change with high specificity and sensitivity. It allows unlabeled binding affinity measurement, target engagement verification and mechanism-of-action elucidation in a single assay platform, vital to informing pharmacology and medicinal chemistry drug discovery efforts.

MSI currently offers Drug Discovery Services to pharmaceutical
companies and will begin shipments of BSI instrumentation in the
second half of 2014.

Website
molsense.com

Source: Scientist.com supplier network, written by the supplier

Get the Molecular Sensing report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Molecular Sensing on Scientist.com

For prices, more details, or to contact Molecular Sensing, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.